speb/financial-data huggingface dataset:
Financial ratios for ATM.L — annual report dated 2022-02-28
Total revenue: 886973.6156351792
Gross profit: 280946.38436482084
Operating income: 44593.355048859936
Net income: -30905.602605863194
Capital expenditures: 296018.5016286645
Operating cash flow: 37072.573289902284
Depreciation & amortization: 123076.28664495115
Net tangible assets: 1771114.2671009772
Owner earnings: -203847.81758957653
Return on net tangible assets (%): -11.509580232970618
Capex to operating income (%): 663.8175156462744
Buffett classification: The Gruesome
Stock price: 0.0009333333333333334
Shares outstanding: 2198914748
Book value: 1789046.0586319221
P/B ratio: 1.1471590804297513
Market cap (USD): 2052320.431466667
Debt to equity: 0.19954743045963713
Current ratio: 3.0499692511980094
Quick ratio: 2.7032104137534914
Effective tax rate (%): 221.7043186470941
Interest coverage ratio: 2.4554490962115856
COGS to revenue (%): 68.32528280295804
SG&A to revenue (%): 16.14347951108498
Free cash flow (dilution-adjusted): -356572.44299674267
Buyback yield (%): 0
Retained earnings: -699630.0325732899
Inventory turnover: 6.406988476741007
Receivables turnover: 14.98188754653283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0817475210082974
FCF margin (%): -40.20102026838692
Rule of 40 score: -40.20102026838692
Financial ratios for ATM.L — annual report dated 2023-02-28
Total revenue: 534683.0250272035
Gross profit: -37102.50272034821
Operating income: -433261.4798694233
Net income: -421861.7519042438
Capital expenditures: 580930.6311207835
Operating cash flow: -268376.0609357998
Depreciation & amortization: 129904.18933623504
Net tangible assets: 1944597.2796517955
Owner earnings: -872888.1936887922
Return on net tangible assets (%): -44.887864588862
Buffett classification: The Gruesome
Stock price: 0.0006024096385542169
Shares outstanding: 2198914748
Book value: 1940647.3884657237
P/B ratio: 0.6825801773301453
Market cap (USD): 1324647.4385542169
Debt to equity: 0.20125756470607795
Current ratio: 1.9688589197239612
Quick ratio: 1.5788799949000825
Interest coverage ratio: -11.888714050257978
COGS to revenue (%): 106.93915852639245
SG&A to revenue (%): 37.48496307392927
Free cash flow (dilution-adjusted): -1008476.6050054408
Buyback yield (%): 0
Retained earnings: -997503.536452666
Inventory turnover: 3.9402540423583887
Receivables turnover: 63.8965039693634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.60007879071464
FCF margin (%): -188.61204822317518
Revenue growth (%): -39.71827170481205
Rule of 40 score: -228.33031992798723
Financial ratios for ATM.L — annual report dated 2024-02-29
Total revenue: 933396.8311688312
Gross profit: 89357.97402597402
Operating income: -414511.5324675325
Net income: -438361.8181818182
Capital expenditures: 612085.0909090909
Operating cash flow: -194123.74025974027
Depreciation & amortization: 175552.25974025973
Net tangible assets: 1689564.155844156
Owner earnings: -874894.6493506494
Return on net tangible assets (%): -51.782268600124645
Buffett classification: The Gruesome
Stock price: 0.0005063291139240507
Shares outstanding: 2198914748
Book value: 1665174.857142857
P/B ratio: 0.6686232086519245
Market cap (USD): 1113374.5559493671
Debt to equity: 0.457429438555745
Current ratio: 1.9210794092608505
Quick ratio: 1.6800856835921922
Interest coverage ratio: -6.994009902855947
COGS to revenue (%): 90.42658266644456
SG&A to revenue (%): 26.697849702878283
Free cash flow (dilution-adjusted): -1017077.4545454545
Buyback yield (%): 0
Retained earnings: -1383045.038961039
Inventory turnover: 5.510292618440232
Receivables turnover: 26.498809846858116
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.78754936929925
FCF margin (%): -108.96517114503546
Revenue growth (%): 74.57012612684721
Rule of 40 score: -34.39504501818824
Financial ratios for ATM.L — annual report dated 2025-02-28
Total revenue: 1291669.180683668
Gross profit: 160505.37167661422
Operating income: -319853.44546934345
Net income: -530184.8073792729
Capital expenditures: 624500.1085187194
Operating cash flow: -216996.63591969616
Depreciation & amortization: 240650.0813890396
Net tangible assets: 1283473.3043950081
Owner earnings: -914034.8345089527
Return on net tangible assets (%): -71.2157262156537
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 2198914748
Book value: 1286494.6283233855
P/B ratio: 0.4327163640785521
Market cap (USD): 556687.2779746836
Debt to equity: 0.9365277981160433
Current ratio: 0.9884339843618465
Quick ratio: 0.7109365264827018
Interest coverage ratio: -2.122032074011411
COGS to revenue (%): 87.5738018622028
SG&A to revenue (%): 19.338191405897042
Free cash flow (dilution-adjusted): -1040253.8795442214
Buyback yield (%): 0
Retained earnings: -2156954.584915898
Inventory turnover: 4.950555589460553
Receivables turnover: 16.263472697982834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.83685543297086
FCF margin (%): -80.5356274734081
Revenue growth (%): 38.38371178807154
Rule of 40 score: -42.15191568533656
Financial ratios for ATM.L — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 1283473.3043950081
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 2198914748
Book value: 1286494.6283233855
P/B ratio: 0.4327163640785521
Market cap (USD): 556687.2779746836
Debt to equity: 0.9365277981160433
Current ratio: 0.9884339843618465
Quick ratio: 0.7109365264827018
Buyback yield (%): 0
Retained earnings: -2156954.584915898
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUGC.V — annual report dated 2022-03-31
Total revenue: 0
Operating income: -126733.6
Net income: -120847.2
Capital expenditures: 213563.2
Operating cash flow: -157152
Net tangible assets: 1594493.6
Owner earnings: -334410.4
Return on net tangible assets (%): -20.972827987519047
Buffett classification: The Gruesome
Stock price: 0.12
Shares outstanding: 39805824
Book value: 1594493.5999999999
P/B ratio: 2.9957466621377473
Market cap (USD): 4776698.88
Debt to equity: 0
Current ratio: 21.39286131459943
Quick ratio: 21.39286131459943
Interest coverage ratio: -565.775
Free cash flow (dilution-adjusted): -376435.2
Buyback yield (%): 0
Retained earnings: -643636
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.948203743182162
Rule of 40 score: 0
Financial ratios for AUGC.V — annual report dated 2023-03-31
Total revenue: 0
Operating income: -134374.07407407407
Net income: -137755.55555555553
Capital expenditures: 619022.9629629629
Operating cash flow: -118219.25925925926
Net tangible assets: 1363627.4074074074
Owner earnings: -756778.5185185184
Return on net tangible assets (%): -55.49745585983354
Buffett classification: The Gruesome
Stock price: 0.02222222222222222
Shares outstanding: 39805824
Book value: 1363627.4074074074
P/B ratio: 0.6486917627656517
Market cap (USD): 884573.8666666666
Debt to equity: 0
Current ratio: 99.99907663896583
Quick ratio: 99.99907663896583
Interest coverage ratio: -762.2058823529412
Free cash flow (dilution-adjusted): -737242.2222222221
Buyback yield (%): 0
Retained earnings: -733714.8148148147
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.779788311696013
Rule of 40 score: 0
Financial ratios for AUGC.V — annual report dated 2024-03-31
Total revenue: 0
Operating income: -98526.66666666666
Net income: -83531.11111111111
Capital expenditures: 46170.370370370365
Operating cash flow: -80439.25925925926
Net tangible assets: 1280096.2962962962
Owner earnings: -129701.48148148147
Return on net tangible assets (%): -10.132165982883233
Buffett classification: The Gruesome
Stock price: 0.014705882352941176
Shares outstanding: 39805824
Book value: 1280096.2962962962
P/B ratio: 0.45729353830611197
Market cap (USD): 585379.7647058823
Debt to equity: 0
Current ratio: 4.3816351188078935
Quick ratio: 4.3816351188078935
Interest coverage ratio: -773.3197674418604
Free cash flow (dilution-adjusted): -126609.62962962962
Buyback yield (%): 0
Retained earnings: -817245.9259259258
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.6968167904035
Rule of 40 score: 0
Financial ratios for AUGC.V — quarterly report dated 2024-09-30
Capital expenditures: 1757.7777777777776
Buffett classification: The Gruesome
Stock price: 0.007407407407407407
Shares outstanding: 39805824
Market cap (USD): 294857.9555555555
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUGC.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -6415.384615384615
Net income: -4960.839160839161
Capital expenditures: 1097.902097902098
Operating cash flow: -5219.580419580419
Net tangible assets: 1174958.041958042
Owner earnings: -6058.741258741259
Return on net tangible assets (%): -0.5156559674798684
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 39805824
Book value: 1174958.041958042
P/B ratio: 0.236912634880579
Market cap (USD): 278362.4055944056
Debt to equity: 0
Current ratio: 2.1452071737786027
Quick ratio: 2.1452071737786027
Interest coverage ratio: -539.6470588235294
Free cash flow (dilution-adjusted): -6317.482517482517
Buyback yield (%): 0
Retained earnings: -807672.7272727273
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.546009677476952
Rule of 40 score: 0
Financial ratios for AUGC.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -25588.81118881119
Net income: -25313.286713286714
Capital expenditures: 0
Operating cash flow: -26204.895104895106
Net tangible assets: 1149644.7552447552
Owner earnings: -25313.286713286714
Return on net tangible assets (%): -2.201835532046385
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 39805824
Book value: 1149644.7552447552
P/B ratio: 0.24212906145528693
Market cap (USD): 278362.4055944056
Debt to equity: 0
Current ratio: 1.3683505782105903
Quick ratio: 1.3683505782105903
Interest coverage ratio: -1925.8947368421052
Free cash flow (dilution-adjusted): -26204.895104895106
Buyback yield (%): 0
Retained earnings: -832986.0139860141
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.2258015854091746
Rule of 40 score: 0
Financial ratios for AUGC.V — annual report dated 2025-03-31
Total revenue: 0
Operating income: -63117.482517482524
Net income: -61460.13986013986
Capital expenditures: 3146.153846153846
Operating cash flow: -58613.28671328672
Net tangible assets: 1149644.7552447552
Owner earnings: -64606.293706293705
Return on net tangible assets (%): -5.619674548294639
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 39805824
Book value: 1149644.7552447552
P/B ratio: 0.24212906145528693
Market cap (USD): 278362.4055944056
Debt to equity: 0
Current ratio: 1.3683505782105903
Quick ratio: 1.3683505782105903
Interest coverage ratio: -644.7
Free cash flow (dilution-adjusted): -61759.44055944056
Buyback yield (%): 0
Retained earnings: -832986.0139860141
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.490172701570325
Rule of 40 score: 0
Financial ratios for AUGC.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -14512.408759124086
Net income: -14528.46715328467
Capital expenditures: 899.9999999999999
Operating cash flow: -8394.160583941606
Net tangible assets: 1185465.6934306568
Owner earnings: -15428.46715328467
Return on net tangible assets (%): -1.3014688859224377
Buffett classification: The Gruesome
Stock price: 0.0218978102189781
Shares outstanding: 39805824
Book value: 1185465.6934306568
P/B ratio: 0.7352894178147982
Market cap (USD): 871660.3795620437
Debt to equity: 0
Current ratio: 0.6235914723600836
Quick ratio: 0.6235914723600836
Interest coverage ratio: -903.7272727272726
Free cash flow (dilution-adjusted): -9294.160583941604
Buyback yield (%): 0
Retained earnings: -883995.6204379562
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2241947480678388
Rule of 40 score: 0
Financial ratios for AUGC.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -16238.848920863311
Net income: -16264.74820143885
Capital expenditures: 0
Operating cash flow: -11128.057553956834
Net tangible assets: 1263654.6762589929
Owner earnings: -16264.74820143885
Return on net tangible assets (%): -1.2871196939333212
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 39805824
Book value: 1263654.6762589929
P/B ratio: 1.1331134997267263
Market cap (USD): 1431864.1726618707
Debt to equity: 0
Current ratio: 3.6025209716882207
Quick ratio: 3.6025209716882207
Interest coverage ratio: -627
Free cash flow (dilution-adjusted): -11128.057553956834
Buyback yield (%): 0
Retained earnings: -887541.0071942447
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2850701402805613
Rule of 40 score: 0
Financial ratios for BELL.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 278.9560439560439
Shares outstanding: 6263555
Market cap (USD): 1747256523.9010987
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BELL.SW — annual report dated 2022-12-31
Total revenue: 4690217391.304348
Gross profit: 1811195652.173913
Operating income: 177065217.39130434
Net income: 138913043.47826087
Capital expenditures: 259347826.0869565
Operating cash flow: 262391304.34782606
Depreciation & amortization: 177065217.39130434
Net tangible assets: 1387826086.9565217
Owner earnings: 56630434.78260875
Return on net tangible assets (%): 4.080513784461156
Capex to operating income (%): 146.47022713321053
Buffett classification: The Gruesome
Stock price: 230.80434782608694
P/E ratio: 10.40691133568075
Shares outstanding: 6263555
Book value: 1600434782.6086955
P/B ratio: 0.9032893702118989
Market cap (USD): 1445655726.847826
Debt to equity: 0.6625916870415648
Current ratio: 2.202183867559
Quick ratio: 1.3064459316660797
Effective tax rate (%): 16.30648330058939
Interest coverage ratio: 19.164705882352944
COGS to revenue (%): 61.383545770567785
SG&A to revenue (%): 0.7833140208574739
Free cash flow (dilution-adjusted): -15000000
Buyback yield (%): 0.04511267108286619
Retained earnings: 1657500000
Inventory turnover: 5.207825403067242
Receivables turnover: 12.639132981839484
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.491591615525623
FCF margin (%): -0.31981460023174973
Rule of 40 score: -0.31981460023174973
Financial ratios for BELL.SW — annual report dated 2023-12-31
Total revenue: 5374047619.047619
Gross profit: 2104761904.761905
Operating income: 196190476.1904762
Net income: 154285714.2857143
Capital expenditures: 377976190.4761905
Operating cash flow: 371071428.5714286
Depreciation & amortization: 207023809.52380952
Net tangible assets: 1596309523.8095238
Owner earnings: -16666666.666666687
Return on net tangible assets (%): -1.0440748750839002
Capex to operating income (%): 192.65776699029126
Buffett classification: The Gruesome
Stock price: 276.59523809523813
P/E ratio: 11.228968894290123
Shares outstanding: 6263555
Book value: 1794404761.9047618
P/B ratio: 0.9654842225834275
Market cap (USD): 1732469486.5476193
Debt to equity: 0.8119816891129836
Current ratio: 2.015419501133787
Quick ratio: 1.2748299319727894
Effective tax rate (%): 14.172185430463577
Interest coverage ratio: 17.72043010752688
COGS to revenue (%): 60.83469939302646
SG&A to revenue (%): 0.7908378007177351
Free cash flow (dilution-adjusted): -21904761.904761907
Buyback yield (%): 0
Retained earnings: 1943571428.5714285
Inventory turnover: 5.605633802816902
Receivables turnover: 13.79645476772616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.309341500765697
FCF margin (%): -0.40760267600017724
Revenue growth (%): 14.579926060806702
Rule of 40 score: 14.172323384806525
Financial ratios for BELL.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1617000000
Buffett classification: The Gruesome
Stock price: 273.27777777777777
Shares outstanding: 6263555
Book value: 1775111111.111111
P/B ratio: 0.964272253536555
Market cap (USD): 1711690391.3888888
Debt to equity: 0.6408988482724087
Current ratio: 1.4338570704510898
Quick ratio: 0.7634313228585909
Buyback yield (%): 0
Retained earnings: 1861222222.222222
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BELL.SW — annual report dated 2024-12-31
Total revenue: 5253666666.666667
Gross profit: 2089000000
Operating income: 185333333.33333334
Net income: 137444444.44444445
Capital expenditures: 334333333.3333333
Operating cash flow: 334777777.7777778
Depreciation & amortization: 204333333.3333333
Net tangible assets: 1617000000
Owner earnings: 7444444.444444478
Return on net tangible assets (%): 0.46038617467189097
Capex to operating income (%): 180.3956834532374
Buffett classification: The Gruesome
Stock price: 273.27777777777777
P/E ratio: 12.453689185529507
Shares outstanding: 6263555
Book value: 1775111111.111111
P/B ratio: 0.964272253536555
Market cap (USD): 1711690391.3888888
Debt to equity: 0.6408988482724087
Current ratio: 1.4338570704510898
Quick ratio: 0.7634313228585909
Effective tax rate (%): 18.938401048492793
Interest coverage ratio: 11.346938775510205
COGS to revenue (%): 60.23729458790685
SG&A to revenue (%): 0.8248207601040543
Free cash flow (dilution-adjusted): -12777777.777777778
Buyback yield (%): 0.10386094276870159
Retained earnings: 1861222222.222222
Inventory turnover: 5.383103383103383
Receivables turnover: 14.051411589895988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.931515957446808
FCF margin (%): -0.2432163779794006
Revenue growth (%): -2.240042532453139
Rule of 40 score: -2.4832589104325393
Financial ratios for BELL.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1825375000
Buffett classification: The Gruesome
Stock price: 300.91249999999997
Shares outstanding: 6263555
Book value: 1990625000
P/B ratio: 0.946829259120879
Market cap (USD): 1884781993.9374998
Debt to equity: 0
Current ratio: 1.9451746800415082
Quick ratio: 0.9612590799031477
Buyback yield (%): 0
Retained earnings: 2123500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHAGCHEM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1672161413688515
Shares outstanding: 129669080
Market cap (USD): 151351843.21244892
Buyback yield (%): 0
Retained earnings: 15426638.533561915
Capitalized R&D asset: 189555.584860873
Rule of 40 score: 0
Financial ratios for BHAGCHEM.NS — annual report dated 2023-03-31
Total revenue: 61144823.3861145
Gross profit: 14699598.051157126
Operating income: 8242399.512789282
Net income: 5499585.87088916
Capital expenditures: 7274153.471376371
Operating cash flow: 1692338.6114494521
Depreciation & amortization: 1194628.5018270402
Net tangible assets: 38094457.97807552
Owner earnings: -579939.098660171
Return on net tangible assets (%): -1.522371309217585
Capex to operating income (%): 88.25286204690107
Buffett classification: The Gruesome
Stock price: 1.4548112058465288
P/E ratio: 34.301497433535026
Shares outstanding: 129669080
Book value: 38154665.04263094
P/B ratio: 4.944193073770518
Market cap (USD): 188644030.63581002
Debt to equity: 0.16024559313365883
Current ratio: 2.2654872087541253
Quick ratio: 1.3591335202600432
Effective tax rate (%): 29.210715691147026
Interest coverage ratio: 27.85465547048654
COGS to revenue (%): 75.95937442106458
R&D to revenue (%): 0.31840700877890193
SG&A to revenue (%): 2.164048135554055
Free cash flow (dilution-adjusted): -5594628.501827041
Buyback yield (%): 0
Retained earnings: 19268294.762484778
Inventory turnover: 4.175713500384373
Receivables turnover: 3.8985611019126285
Capitalized R&D asset: 321691.6450236546
ROCI (R&D-adjusted, %): 19.557460941957263
FCF margin (%): -9.149799103185465
Rule of 40 score: -9.149799103185465
Financial ratios for BHAGCHEM.NS — annual report dated 2024-03-31
Total revenue: 48866602.7101571
Gross profit: 10982156.133828996
Operating income: 3847667.586041492
Net income: 2185082.1441419832
Capital expenditures: 9480105.528240796
Operating cash flow: 4111752.0086341286
Depreciation & amortization: 1316704.6408442259
Net tangible assets: 49343242.595035374
Owner earnings: -5978318.743254587
Return on net tangible assets (%): -12.115780051828393
Capex to operating income (%): 246.38577310141278
Buffett classification: The Gruesome
Stock price: 1.9279030710172746
P/E ratio: 114.40733165029275
Shares outstanding: 129669080
Book value: 49611859.93524403
P/B ratio: 5.038904364284745
Market cap (USD): 249989417.54798466
Debt to equity: 0.14898916713579188
Current ratio: 2.2331618064734062
Quick ratio: 1.3449434630579902
Effective tax rate (%): 32.31830979637622
Interest coverage ratio: 6.083865829841295
COGS to revenue (%): 77.52625407792812
R&D to revenue (%): 0.615707636786973
SG&A to revenue (%): 2.8839608283316798
Free cash flow (dilution-adjusted): -5368353.519606668
Buyback yield (%): 0
Retained earnings: 20810408.921933085
Inventory turnover: 2.833630971334366
Receivables turnover: 3.8047498380058005
Capitalized R&D asset: 493870.64785067795
ROCI (R&D-adjusted, %): 7.190326511885507
Rosenberg metric: -19.094218056346314
FCF margin (%): -10.985730993922433
Revenue growth (%): -20.080556285891063
Rule of 40 score: -31.066287279813494
Financial ratios for BHAGCHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 74594445.77161969
Buffett classification: The Gruesome
Stock price: 4.06438127090301
Shares outstanding: 129669080
Book value: 74893251.31390348
P/B ratio: 7.037010290263432
Market cap (USD): 527024580.1672241
Debt to equity: 0.13981661747258364
Current ratio: 2.9018550357318
Quick ratio: 2.13766765365761
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHAGCHEM.NS — annual report dated 2025-03-31
Total revenue: 51474292.72854804
Gross profit: 11041501.05213935
Operating income: 2716506.897357961
Net income: 1619978.9572129997
Capital expenditures: 29076093.05588029
Operating cash flow: -6172422.258592471
Depreciation & amortization: 1620762.2165068972
Net tangible assets: 79394926.35024549
Owner earnings: -25835351.88216039
Return on net tangible assets (%): -32.5403058731857
Capex to operating income (%): 1070.3485820028402
Buffett classification: The Gruesome
Stock price: 3.2430855409032557
P/E ratio: 259.5885067381991
Shares outstanding: 129669080
Book value: 79754722.93663782
P/B ratio: 5.272765084825402
Market cap (USD): 420527918.45022756
Debt to equity: 0.13033002898323845
Current ratio: 1.9199391770671528
Quick ratio: 1.2556248153059097
Effective tax rate (%): 45.11873455421077
Interest coverage ratio: 4.519322403096252
COGS to revenue (%): 78.54948467117909
R&D to revenue (%): 0.6859014001691077
SG&A to revenue (%): 2.8159181088098846
Free cash flow (dilution-adjusted): -35665419.68669628
Buyback yield (%): 0
Retained earnings: 21774000.467617486
Inventory turnover: 2.666407372086694
Receivables turnover: 2.5325510595551495
Capitalized R&D asset: 618896.9187629306
ROCI (R&D-adjusted, %): 3.207425970866664
Rosenberg metric: 0.19724084248307616
FCF margin (%): -69.28782853759536
Revenue growth (%): 5.336343993172516
Rule of 40 score: -63.95148454442284
Financial ratios for BHAGCHEM.NS — quarterly report dated 2025-03-31
Total revenue: 14335071.311667055
Gross profit: 4549777.881692775
Operating income: 290133.2709843348
Net income: -103366.8459200374
Capital expenditures: 0
Depreciation & amortization: 420294.59901800327
Net tangible assets: 79394926.35024549
Owner earnings: 316927.75309796585
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.2430855409032557
Shares outstanding: 129669080
Book value: 79754722.93663782
P/B ratio: 5.272765084825402
Market cap (USD): 420527918.45022756
Debt to equity: 0.13033002898323845
Current ratio: 1.9199391770671528
Quick ratio: 1.2556248153059097
Effective tax rate (%): 139.36425963850058
Interest coverage ratio: 1.5986859056944087
COGS to revenue (%): 68.26121208068359
Buyback yield (%): 0
Retained earnings: 21774000.467617486
Inventory turnover: 0.6453073720095998
Receivables turnover: 0.705289924635067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.33633310990630977
Rule of 40 score: 0
Financial ratios for BHAGCHEM.NS — quarterly report dated 2025-06-30
Total revenue: 14483711.677978002
Gross profit: 4858916.452141353
Operating income: 599672.361338638
Net income: 465609.6419377487
Capital expenditures: 0
Depreciation & amortization: 452375.38029487483
Owner earnings: 917985.0222326235
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.520243388719869
P/E ratio: 245.09088755748783
Shares outstanding: 129669080
Market cap (USD): 456466721.5913878
Effective tax rate (%): -59.0749180458943
Interest coverage ratio: 1.5715424716344681
COGS to revenue (%): 66.45254641785523
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.0369000828755623
Rule of 40 score: 1.0369000828755623
Financial ratios for BHAGCHEM.NS — quarterly report dated 2025-09-30
Total revenue: 15794498.308906425
Gross profit: 5495580.608793686
Operating income: 1251837.655016911
Net income: 620552.4239007891
Capital expenditures: 0
Depreciation & amortization: 445839.9098083427
Net tangible assets: 77398241.2626832
Owner earnings: 1066392.333709132
Return on net tangible assets (%): 1.3777991803326446
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.8844419391206313
P/E ratio: 380.5705654431292
Shares outstanding: 129669080
Book value: 77754881.62344983
P/B ratio: 4.810282322472059
Market cap (USD): 374022932.55918825
Debt to equity: 0.27379032597162356
Current ratio: 1.8908418412512489
Quick ratio: 1.366366390994528
Effective tax rate (%): 26.670929752341365
Interest coverage ratio: 2.734117994681375
COGS to revenue (%): 65.20572859414749
Buyback yield (%): 0
Inventory turnover: 0.8402670785000704
Receivables turnover: 0.6610235548018824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3342574610536162
Revenue growth (%): 9.050074042287312
Rule of 40 score: 9.050074042287312
Financial ratios for BHAGCHEM.NS — quarterly report dated 2025-12-31
Total revenue: 12695978.612008467
Gross profit: 5455385.9864097135
Operating income: 979993.3162526457
Net income: 514180.68397014594
Capital expenditures: 0
Depreciation & amortization: 543132.4495934054
Owner earnings: 1057313.1335635514
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.447476885373733
P/E ratio: 212.00212723750337
Shares outstanding: 129669080
Market cap (USD): 317362076.0476774
Effective tax rate (%): 26.606350670207185
Interest coverage ratio: 2.8410786371709995
COGS to revenue (%): 57.030598797246334
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -19.617715208787104
Rule of 40 score: -19.617715208787104
Financial ratios for BSD2.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8181818181818183
Shares outstanding: 14294084458
Market cap (USD): 40283328927.09091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSD2.DE — annual report dated 2022-12-31
Total revenue: 57676595744.680855
Net income: 11451063829.787235
Capital expenditures: 3731914893.6170216
Operating cash flow: 29474468085.106384
Depreciation & amortization: 3175531914.893617
Net tangible assets: 74956382978.7234
Owner earnings: 10894680851.063831
Return on net tangible assets (%): 14.534693935480211
Buffett classification: The Gruesome
Stock price: 2.6276595744680855
P/E ratio: 3.2800435350483093
Shares outstanding: 14294084458
Book value: 103813829787.23413
P/B ratio: 0.36180138967320774
Market cap (USD): 37559987884.31915
Debt to equity: 2.8996362145821566
Effective tax rate (%): 29.41639344262295
COGS to revenue (%): 0
SG&A to revenue (%): 37.55164527076878
Free cash flow (dilution-adjusted): 17942553191.489365
Buyback yield (%): 5.80631460943646
Retained earnings: 81177659574.4681
Receivables turnover: 1.1057043215793445
Capitalized R&D asset: 0
FCF margin (%): 31.108897742363883
Rule of 40 score: 31.108897742363883
Financial ratios for BSD2.DE — annual report dated 2023-12-31
Total revenue: 62985555555.55556
Net income: 13536666666.666666
Capital expenditures: 4857777777.777778
Operating cash flow: 5572222222.222222
Depreciation & amortization: 3428888888.888889
Net tangible assets: 83946666666.66667
Owner earnings: 12107777777.777779
Return on net tangible assets (%): 14.423178737822957
Buffett classification: The Gruesome
Stock price: 3.8666666666666667
P/E ratio: 4.0830184612853975
Shares outstanding: 14294084458
Book value: 115823333333.33325
P/B ratio: 0.47719624633148217
Market cap (USD): 55270459904.26667
Debt to equity: 2.9832695388570736
Effective tax rate (%): 25.85804731756081
COGS to revenue (%): 0
SG&A to revenue (%): 38.917212059202285
Free cash flow (dilution-adjusted): -9586666666.666666
Buyback yield (%): 6.250073638663127
Retained earnings: 94655555555.55556
Receivables turnover: 5.336251529699708
Capitalized R&D asset: 0
FCF margin (%): -15.22042090779191
Revenue growth (%): 9.204703818470968
Rule of 40 score: -6.015717089320942
Financial ratios for BSD2.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.788888888888889
Shares outstanding: 14294084458
Market cap (USD): 68452782237.755554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSD2.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.385416666666667
Shares outstanding: 14294084458
Market cap (USD): 62685516216.85417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSD2.DE — annual report dated 2024-12-31
Total revenue: 62817708333.333336
Net income: 14316666666.666668
Capital expenditures: 2633333333.3333335
Operating cash flow: -25161458333.333336
Depreciation & amortization: 3311458333.3333335
Net tangible assets: 82647916666.66667
Owner earnings: 14994791666.666666
Return on net tangible assets (%): 18.14297597741423
Buffett classification: The Gruesome
Stock price: 4.385416666666667
P/E ratio: 4.378499386509023
Shares outstanding: 14294084458
Book value: 111798958333.33325
P/B ratio: 0.5606985713583725
Market cap (USD): 62685516216.85417
Debt to equity: 3.053500051245262
Effective tax rate (%): 27.924136738340927
COGS to revenue (%): 0
SG&A to revenue (%): 36.31042202139126
Free cash flow (dilution-adjusted): -36201041666.66667
Buyback yield (%): 7.958045123867712
Retained earnings: 98854166666.66667
Receivables turnover: 5.277875021879923
Capitalized R&D asset: 0
FCF margin (%): -57.628720669927866
Revenue growth (%): -0.26648526117099025
Rule of 40 score: -57.89520593109886
Financial ratios for BSD2.DE — quarterly report dated 2025-03-31
Total revenue: 16306521739.130434
Net income: 4066304347.826087
Capital expenditures: 0
Depreciation & amortization: 893478260.8695651
Net tangible assets: 89385869565.21739
Owner earnings: 4959782608.695652
Return on net tangible assets (%): 5.548732291603332
Buffett classification: The Gruesome
Stock price: 6.467391304347826
P/E ratio: 5.683627541105319
Shares outstanding: 14294084458
Book value: 120123913043.47827
P/B ratio: 0.7695839669643665
Market cap (USD): 92445437527.28261
Debt to equity: 2.8794179922905694
Effective tax rate (%): 28.236297718063557
COGS to revenue (%): 0
SG&A to revenue (%): 33.862151713104915
Buyback yield (%): 0
Retained earnings: 106818478260.86957
Receivables turnover: 1.5187284875480866
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSD2.DE — quarterly report dated 2025-06-30
Total revenue: 16861176470.588236
Net income: 4378823529.411765
Capital expenditures: 0
Depreciation & amortization: 945882352.9411765
Net tangible assets: 97943529411.76471
Owner earnings: 5324705882.3529415
Return on net tangible assets (%): 5.436506029885168
Buffett classification: The Gruesome
Stock price: 8.058823529411764
P/E ratio: 13.640232076533783
Shares outstanding: 14294084458
Book value: 128217647058.82349
P/B ratio: 0.8984216042326929
Market cap (USD): 115193504161.5294
Debt to equity: 2.862439785291555
Effective tax rate (%): 23.62400906002265
COGS to revenue (%): 0
SG&A to revenue (%): 37.008093776165225
Buyback yield (%): 0
Retained earnings: 116220000000
Receivables turnover: 0.28527070063694265
Capitalized R&D asset: 0
Revenue growth (%): 3.4014288290973047
Rule of 40 score: 3.4014288290973047
Financial ratios for BSD2.DE — quarterly report dated 2025-09-30
Total revenue: 16678823529.411766
Net income: 4576470588.235294
Capital expenditures: 0
Depreciation & amortization: 936470588.2352941
Net tangible assets: 98576470588.23529
Owner earnings: 5512941176.470589
Return on net tangible assets (%): 5.592552810597924
Buffett classification: The Gruesome
Stock price: 10.188235294117648
P/E ratio: 11.183841688732532
Shares outstanding: 14294084458
Book value: 129310588235.29395
P/B ratio: 1.1262147807038247
Market cap (USD): 145631495772.09415
Debt to equity: 2.880643048201325
Effective tax rate (%): 25.61735022546704
COGS to revenue (%): 0
SG&A to revenue (%): 36.81314805671157
Buyback yield (%): 0
Retained earnings: 120342352941.17647
Receivables turnover: 1.4324542790744672
Capitalized R&D asset: 0
Revenue growth (%): -1.0814959531119126
Rule of 40 score: -1.0814959531119126
Financial ratios for BSD2.DE — quarterly report dated 2025-12-31
Total revenue: 17621176470.588234
Net income: 4878823529.411765
Capital expenditures: 0
Depreciation & amortization: 889411764.7058824
Net tangible assets: 101014117647.05882
Owner earnings: 5768235294.117647
Return on net tangible assets (%): 5.710325871747688
Buffett classification: The Gruesome
Stock price: 11.741176470588236
P/E ratio: 9.37572131845988
Shares outstanding: 14294084458
Book value: 132644705882.35303
P/B ratio: 1.2652549303831548
Market cap (USD): 167829368106.8706
Debt to equity: 2.893284138077836
Effective tax rate (%): 23.638211382113823
COGS to revenue (%): 0
SG&A to revenue (%): 37.22793430364535
Buyback yield (%): 0
Retained earnings: 124776470588.23529
Receivables turnover: 1.345490477901545
Capitalized R&D asset: 0
Revenue growth (%): 5.649996473160736
Rule of 40 score: 5.649996473160736
Financial ratios for BSD2.DE — annual report dated 2025-12-31
Total revenue: 70615294117.64706
Net income: 18235294117.64706
Capital expenditures: 762352941.1764706
Operating cash flow: -17452941176.47059
Depreciation & amortization: 3738823529.4117646
Net tangible assets: 101014117647.05882
Owner earnings: 21211764705.882355
Return on net tangible assets (%): 20.998812047238594
Buffett classification: The Gruesome
Stock price: 11.741176470588236
P/E ratio: 9.20354599295742
Shares outstanding: 14294084458
Book value: 132644705882.35303
P/B ratio: 1.2652549303831548
Market cap (USD): 167829368106.8706
Debt to equity: 2.893284138077836
Effective tax rate (%): 25.282372464000858
COGS to revenue (%): 0
SG&A to revenue (%): 35.76628958899089
Free cash flow (dilution-adjusted): -26463529411.764706
Buyback yield (%): 2.8607487025339546
Retained earnings: 124776470588.23529
Receivables turnover: 5.391933165648581
Capitalized R&D asset: 0
FCF margin (%): -37.4756343401696
Revenue growth (%): 12.41303764686374
Rule of 40 score: -25.062596693305856
Financial ratios for CAS.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.952755905511811
Shares outstanding: 101314493
Market cap (USD): 907043925.519685
Buyback yield (%): 2.2570506641287893
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAS.TO — annual report dated 2022-12-31
Total revenue: 3283823529.4117646
Gross profit: 1198529411.764706
Operating income: 105882352.94117646
Net income: -10294117.647058822
Capital expenditures: 354411764.7058823
Operating cash flow: 105882352.94117646
Depreciation & amortization: 185294117.6470588
Net tangible assets: 963235294.1176469
Owner earnings: -179411764.7058823
Return on net tangible assets (%): -18.62595419847328
Capex to operating income (%): 334.72222222222223
Buffett classification: The Gruesome
Stock price: 5.3161764705882355
Shares outstanding: 101314493
Book value: 1417647058.8235292
P/B ratio: 0.37992934875000006
Market cap (USD): 538605723.8161765
Debt to equity: 1.0726141078838174
Current ratio: 1.3794983642311887
Quick ratio: 0.7393675027262813
Interest coverage ratio: 1.87012987012987
COGS to revenue (%): 63.502015226153155
SG&A to revenue (%): 22.212270488132557
Free cash flow (dilution-adjusted): -266176470.5882353
Buyback yield (%): 1.2286625942137406
Retained earnings: 891176470.5882353
Inventory turnover: 4.8313458262350935
Receivables turnover: 7.8765432098765435
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.481624758220503
FCF margin (%): -8.105687416032243
Rule of 40 score: -8.105687416032243
Financial ratios for CAS.TO — annual report dated 2023-12-31
Total revenue: 3513636363.6363635
Gross profit: 1437121212.121212
Operating income: 207575757.57575756
Net income: -40151515.15151515
Capital expenditures: 259848484.84848484
Operating cash flow: 386363636.3636364
Depreciation & amortization: 206060606.06060606
Net tangible assets: 910606060.6060605
Owner earnings: -93939393.93939394
Return on net tangible assets (%): -10.316139767054908
Capex to operating income (%): 125.18248175182482
Buffett classification: The Gruesome
Stock price: 8.575757575757576
Shares outstanding: 101314493
Book value: 1349242424.242424
P/B ratio: 0.6439528696013477
Market cap (USD): 868848530.8787879
Debt to equity: 1.0870297585626054
Current ratio: 1.3284493284493286
Quick ratio: 0.634920634920635
Interest coverage ratio: 2.2096774193548385
COGS to revenue (%): 59.09874946097457
SG&A to revenue (%): 23.329021129797326
Free cash flow (dilution-adjusted): 120454545.45454545
Buyback yield (%): 0
Retained earnings: 830303030.3030303
Inventory turnover: 4.825704225352113
Receivables turnover: 9.974193548387097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.931444472552492
FCF margin (%): 3.428201811125485
Revenue growth (%): 6.998330822782233
Rule of 40 score: 10.426532633907717
Financial ratios for CAS.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.133333333333334
Shares outstanding: 101314493
Market cap (USD): 722710050.0666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAS.TO — annual report dated 2024-12-31
Total revenue: 3287412587.4125876
Gross profit: 1296503496.5034966
Operating income: 139860139.86013988
Net income: -9790209.79020979
Capital expenditures: 88811188.81118882
Operating cash flow: 190209790.20979023
Depreciation & amortization: 197202797.2027972
Net tangible assets: 824475524.4755245
Owner earnings: 98601398.60139859
Capex to operating income (%): 63.5
Buffett classification: The Good
Stock price: 7.776223776223776
Shares outstanding: 101314493
Book value: 1238461538.4615383
P/B ratio: 0.6361474659288537
Market cap (USD): 787844169.3426573
Debt to equity: 1.1987577639751554
Current ratio: 1.0910763569457222
Quick ratio: 0.4609015639374425
Interest coverage ratio: 1.4492753623188406
COGS to revenue (%): 60.561582641991066
SG&A to revenue (%): 23.101467772814296
Free cash flow (dilution-adjusted): 61538461.53846154
Buyback yield (%): 0
Retained earnings: 712587412.5874126
Inventory turnover: 4.156204379562044
Receivables turnover: 9.938689217758986
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.180005180005181
FCF margin (%): 1.8719421399702192
Revenue growth (%): -6.438451587222599
Rule of 40 score: -4.56650944725238
Financial ratios for CAS.TO — quarterly report dated 2024-12-31
Total revenue: 846853146.8531469
Gross profit: 342657342.6573427
Operating income: 54545454.54545455
Net income: -4895104.895104895
Capital expenditures: 20279720.27972028
Operating cash flow: 107692307.6923077
Depreciation & amortization: 53146853.14685315
Net tangible assets: 824475524.4755245
Owner earnings: 27972027.972027976
Capex to operating income (%): 37.17948717948718
Buffett classification: The Good
Stock price: 7.776223776223776
Shares outstanding: 101314493
Book value: 1238461538.4615383
P/B ratio: 0.6361474659288537
Market cap (USD): 787844169.3426573
Debt to equity: 1.1987577639751554
Current ratio: 1.0910763569457222
Quick ratio: 0.4609015639374425
Interest coverage ratio: 2.3636363636363633
COGS to revenue (%): 59.53757225433526
SG&A to revenue (%): 22.873658133773738
Free cash flow (dilution-adjusted): 74125874.12587413
Buyback yield (%): 0
Retained earnings: 712587412.5874126
Inventory turnover: 1.0525547445255474
Receivables turnover: 2.5602536997885834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0202020202020203
FCF margin (%): 8.75309661436829
Rule of 40 score: 8.75309661436829
Financial ratios for CAS.TO — quarterly report dated 2025-03-31
Total revenue: 806993006.9930071
Gross profit: 332167832.1678322
Operating income: 36363636.36363637
Net income: 8391608.391608393
Capital expenditures: 25174825.174825177
Operating cash flow: -36363636.36363637
Depreciation & amortization: 48251748.25174826
Net tangible assets: 821678321.6783217
Owner earnings: 31468531.468531474
Return on net tangible assets (%): 3.829787234042554
Capex to operating income (%): 69.23076923076923
Buffett classification: The Good
Stock price: 6.405594405594406
P/E ratio: 19.334182414166666
Shares outstanding: 101314493
Book value: 1235664335.6643357
P/B ratio: 0.5252069925749858
Market cap (USD): 648979549.5664335
Debt to equity: 1.270514997170345
Current ratio: 1.094240837696335
Quick ratio: 0.45375218150087265
Effective tax rate (%): 29.411764705882348
Interest coverage ratio: 1.4857142857142858
COGS to revenue (%): 58.83882149046794
SG&A to revenue (%): 24.263431542461007
Free cash flow (dilution-adjusted): -61538461.53846154
Buyback yield (%): 0
Retained earnings: 708391608.3916085
Inventory turnover: 0.9250681198910082
Receivables turnover: 2.3599182004089982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.331626120358515
FCF margin (%): -7.625649913344887
Revenue growth (%): -4.7068538398018145
Rule of 40 score: -12.332503753146701
Financial ratios for CAS.TO — quarterly report dated 2025-06-30
Total revenue: 866423357.6642336
Gross profit: 354014598.54014593
Operating income: 46715328.46715328
Net income: 2189781.02189781
Capital expenditures: 13138686.131386861
Operating cash flow: 48905109.48905109
Depreciation & amortization: 52554744.525547445
Net tangible assets: 838686131.3868612
Owner earnings: 41605839.41605839
Return on net tangible assets (%): 4.960835509138382
Capex to operating income (%): 28.125
Buffett classification: The Good
Stock price: 6.226277372262773
P/E ratio: 110.93573197169655
Shares outstanding: 101314493
Book value: 1242335766.4233575
P/B ratio: 0.5077629995828438
Market cap (USD): 630812135.2481751
Debt to equity: 1.2514688601645123
Current ratio: 1.5413436692506461
Quick ratio: 0.6563307493540053
Effective tax rate (%): 50
Interest coverage ratio: 2.064516129032258
COGS to revenue (%): 59.14069081718618
SG&A to revenue (%): 23.167649536647005
Free cash flow (dilution-adjusted): 16788321.16788321
Buyback yield (%): 0
Retained earnings: 728467153.2846714
Inventory turnover: 1.0248175182481754
Receivables turnover: 2.488469601677149
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5853356452811491
FCF margin (%): 1.9376579612468408
Revenue growth (%): 7.364419537249037
Rule of 40 score: 9.302077498495878
Financial ratios for CAS.TO — quarterly report dated 2025-12-31
Total revenue: 873722627.7372262
Gross profit: 361313868.6131387
Operating income: 75912408.75912409
Net income: 31386861.313868612
Capital expenditures: 29927007.29927007
Operating cash flow: 133576642.33576642
Depreciation & amortization: 52554744.525547445
Net tangible assets: 875912408.759124
Owner earnings: 54014598.540145986
Return on net tangible assets (%): 6.166666666666667
Capex to operating income (%): 39.42307692307692
Buffett classification: The Good
Stock price: 8.897810218978101
P/E ratio: 24.316175790005502
Shares outstanding: 101314493
Book value: 1281021897.810219
P/B ratio: 0.7037171906951566
Market cap (USD): 901477131.1459852
Debt to equity: 1.1076923076923075
Current ratio: 1.4262701363073111
Quick ratio: 0.6071871127633209
Effective tax rate (%): 12.244897959183675
Interest coverage ratio: 3.3548387096774195
COGS to revenue (%): 58.64661654135338
SG&A to revenue (%): 22.80701754385965
Free cash flow (dilution-adjusted): 102919708.02919707
Buyback yield (%): 0
Retained earnings: 760583941.6058394
Inventory turnover: 1.0620272314674735
Receivables turnover: 2.732876712328767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.690118986032074
FCF margin (%): 11.779448621553884
Revenue growth (%): 0.8424599831507982
Rule of 40 score: 12.621908604704682
Financial ratios for CAS.TO — annual report dated 2025-12-31
Total revenue: 3486131386.861314
Gross profit: 1422627737.2262774
Operating income: 215328467.15328467
Net income: 67883211.67883211
Capital expenditures: 91240875.91240875
Operating cash flow: 276642335.76642334
Depreciation & amortization: 209489051.0948905
Net tangible assets: 875912408.759124
Owner earnings: 186131386.86131388
Return on net tangible assets (%): 21.250000000000004
Capex to operating income (%): 42.3728813559322
Buffett classification: The Good
Stock price: 8.897810218978101
P/E ratio: 13.279824405053763
Shares outstanding: 101314493
Book value: 1281021897.810219
P/B ratio: 0.7037171906951566
Market cap (USD): 901477131.1459852
Debt to equity: 1.1076923076923075
Current ratio: 1.4262701363073111
Quick ratio: 0.6071871127633209
Effective tax rate (%): 19.130434782608695
Interest coverage ratio: 2.234848484848485
COGS to revenue (%): 59.191792294807364
SG&A to revenue (%): 22.969011725293132
Free cash flow (dilution-adjusted): 165693430.6569343
Buyback yield (%): 0
Retained earnings: 760583941.6058394
Inventory turnover: 4.276853252647504
Receivables turnover: 10.904109589041097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.630625969994827
FCF margin (%): 4.752931323283081
Revenue growth (%): 6.044839038750871
Rule of 40 score: 10.797770362033951
Financial ratios for CCA.AX — annual report dated 2021-06-30
Total revenue: 4609653.383458646
Gross profit: 4609653.383458646
Operating income: -2217982.7067669174
Net income: -2614572.9323308268
Capital expenditures: 30829.323308270676
Depreciation & amortization: 477784.2105263158
Net tangible assets: 1132972.1804511277
Owner earnings: -2167618.0451127817
Return on net tangible assets (%): -191.3213830413451
Buffett classification: The Gruesome
Stock price: 0.08270676691729323
Shares outstanding: 690453020
Book value: 5278699.2481203005
P/B ratio: 10.818031925727887
Market cap (USD): 57105136.9924812
Debt to equity: 0.08001487037561941
Current ratio: 1.2500501550035057
Quick ratio: 1.2500501550035057
COGS to revenue (%): 0
SG&A to revenue (%): 89.5127241149213
Free cash flow (dilution-adjusted): -1835758.6466165413
Buyback yield (%): 0.798669308975774
Retained earnings: -30215339.84962406
Receivables turnover: 2.4937853042998284
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -40.274065216058695
FCF margin (%): -39.824223079418665
Rule of 40 score: -39.824223079418665
Financial ratios for CCA.AX — annual report dated 2022-06-30
Total revenue: 5625116.551724138
Gross profit: 5625116.551724138
Operating income: -2599693.103448276
Net income: -2598960.6896551726
Capital expenditures: 30209.655172413793
Depreciation & amortization: 755080.6896551724
Net tangible assets: -1827048.9655172415
Owner earnings: -1874089.655172414
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 690453020
Book value: 2306002.7586206896
P/B ratio: 12.389607812174763
Market cap (USD): 28570469.79310345
Debt to equity: 0.3869400521098758
Current ratio: 0.6797809128183181
Quick ratio: 0.6797809128183181
Interest coverage ratio: -42.62611242409508
COGS to revenue (%): 0
SG&A to revenue (%): 92.03050995786263
Free cash flow (dilution-adjusted): -2246476.551724138
Buyback yield (%): 0
Retained earnings: -30313720.689655174
Receivables turnover: 4.50905163859342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -82.64976611959365
FCF margin (%): -39.93653342232664
Revenue growth (%): 22.02905693320448
Rule of 40 score: -17.90747648912216